Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
NPJ Vaccines|August 18, 2023
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)Chandramani Singh, Savita Verma, Prabhakar Reddy, et al.Medical Image Analysis|March 19, 2021
LNDb challenge on automatic lung cancer patient managementJoão Pedrosa, Guilherme Aresta, Carlos Ferreira, et al.Journal of Cardiovascular Electrophysiology|June 9, 2026
Invasive Assessment of Right Ventricular Dysfunction Predicts Periprocedural Outcomes in Patients Undergoing Unplanned Ventricular Tachycardia AblationTess Calcagno, Sai Prasad Ramachandran, V Karthik, et al.The Lancet. Infectious Diseases|March 11, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trialRaches Ella, Siddharth Reddy, Harsh Jogdand, et al.Lancet (London, England)|November 14, 2021
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddarth Reddy, William Blackwelder, et al.Lancet (London, England)|March 18, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trialNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.Vaccine|August 6, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of lifeNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Margarita Garcia-Calvo, JeanMarie Lisnock, Herbert G Bull, et al.Blood|October 7, 2025
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemiaJennifer R Brown, Bastien Nguyen, Sai Prasad Desikan, et al.Nature Communications|March 3, 2021
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaquesPragya D Yadav, Raches Ella, Sanjay Kumar, et al.Pageof 17